PERINI, PAOLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.775
AS - Asia 2.077
EU - Europa 872
SA - Sud America 338
AF - Africa 285
OC - Oceania 37
Continente sconosciuto - Info sul continente non disponibili 23
Totale 7.407
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.611
SG - Singapore 725
CN - Cina 398
VN - Vietnam 329
BR - Brasile 233
HK - Hong Kong 199
IT - Italia 124
FI - Finlandia 97
DE - Germania 90
FR - Francia 88
SE - Svezia 69
IN - India 50
GB - Regno Unito 40
BD - Bangladesh 38
UA - Ucraina 37
IQ - Iraq 34
NL - Olanda 32
ZA - Sudafrica 32
RU - Federazione Russa 30
PL - Polonia 28
TR - Turchia 27
EC - Ecuador 25
CA - Canada 23
ES - Italia 23
JP - Giappone 22
AR - Argentina 21
MX - Messico 21
PK - Pakistan 21
AT - Austria 18
CO - Colombia 16
IE - Irlanda 15
ID - Indonesia 14
KG - Kirghizistan 14
SA - Arabia Saudita 13
UZ - Uzbekistan 13
CY - Cipro 12
PH - Filippine 12
TN - Tunisia 12
AO - Angola 11
AU - Australia 11
BJ - Benin 11
CH - Svizzera 11
CI - Costa d'Avorio 11
CR - Costa Rica 11
JO - Giordania 11
KE - Kenya 11
BA - Bosnia-Erzegovina 10
BG - Bulgaria 10
DK - Danimarca 10
HR - Croazia 10
MA - Marocco 10
MD - Moldavia 10
NE - Niger 10
VE - Venezuela 10
AD - Andorra 9
AE - Emirati Arabi Uniti 9
CL - Cile 9
DZ - Algeria 9
IR - Iran 9
JM - Giamaica 9
LB - Libano 9
MG - Madagascar 9
MK - Macedonia 9
NC - Nuova Caledonia 9
TH - Thailandia 9
TT - Trinidad e Tobago 9
AZ - Azerbaigian 8
CV - Capo Verde 8
EG - Egitto 8
KR - Corea 8
LV - Lettonia 8
MN - Mongolia 8
PY - Paraguay 8
RE - Reunion 8
SN - Senegal 8
VC - Saint Vincent e Grenadine 8
AM - Armenia 7
BB - Barbados 7
BS - Bahamas 7
CZ - Repubblica Ceca 7
ET - Etiopia 7
GR - Grecia 7
GT - Guatemala 7
IL - Israele 7
IS - Islanda 7
KH - Cambogia 7
KZ - Kazakistan 7
PA - Panama 7
PR - Porto Rico 7
PS - Palestinian Territory 7
RO - Romania 7
RS - Serbia 7
SI - Slovenia 7
ZW - Zimbabwe 7
AF - Afghanistan, Repubblica islamica di 6
AL - Albania 6
BE - Belgio 6
BO - Bolivia 6
BW - Botswana 6
BZ - Belize 6
Totale 7.124
Salva come PNG Salva come JPEG
Città #
Singapore 417
San Jose 379
Ashburn 322
Chandler 319
Fairfield 319
Woodbridge 270
Ann Arbor 197
Hong Kong 183
Santa Clara 173
Cambridge 132
Wilmington 130
Seattle 118
Houston 117
Ho Chi Minh City 108
Jacksonville 99
Beijing 94
Hanoi 77
Princeton 68
Boardman 64
Los Angeles 64
Helsinki 45
Council Bluffs 44
Lauterbourg 40
Nanjing 35
San Diego 26
Medford 25
New York 25
São Paulo 24
Buffalo 23
Da Nang 22
Guangzhou 20
The Dalles 19
Munich 18
Norwalk 18
Roxbury 18
Bytom 17
Orem 17
Des Moines 16
Tokyo 16
Haiphong 15
Padova 15
Redondo Beach 15
Baghdad 14
Milan 13
Tashkent 13
Dublin 12
Amman 11
Bishkek 11
Chicago 11
Cotonou 11
Frankfurt am Main 11
Luanda 11
Abidjan 10
Dallas 10
Johannesburg 10
Nairobi 10
Nicosia 10
Nuremberg 10
Shenyang 10
Vienna 10
Amsterdam 9
Andorra la Vella 9
Antananarivo 9
Brooklyn 9
Istanbul 9
Niamey 9
Noumea 9
San José 9
Stockholm 9
Brasília 8
Dakar 8
Guayaquil 8
Hải Dương 8
Jiaxing 8
Kingstown 8
London 8
Nanchang 8
Riga 8
Ulan Bator 8
Baku 7
Bridgetown 7
Campinas 7
Chennai 7
Chisinau 7
Harare 7
Nassau 7
New Delhi 7
Phnom Penh 7
Praia 7
Skopje 7
Bamako 6
Belo Horizonte 6
Biên Hòa 6
Buenos Aires 6
Cape Town 6
Changsha 6
Dhaka 6
Falkenstein 6
Guatemala City 6
Havana 6
Totale 4.659
Salva come PNG Salva come JPEG
Nome #
Cortical relapses in multiple sclerosis 273
MRI-detectable cortical lesions in the cerebellum and their clinical relevance in multiple sclerosis 258
A case of relapsing-remitting tumour-like inflammation of the central nervous system 236
Cortical pathology in multiple sclerosis patients with epilepsy: a 3 year longitudinal study. 233
Gray matter pathology in MS: A 3-year longitudinal study in a pediatric population 222
Cerebrospinal fluid IL-1β correlates with cortical pathology load in multiple sclerosis at clinical onset 220
Investigation of the neural correlates underlying action observation in multiple sclerosis patients 219
Crisi epilettiche all’esordio e al follow-up in ADEM e sclerosi multipla in età pediatrica: dati a confronto dalla casistica padovana 206
Natalizumab strongly suppresses cortical pathology in relapsing-remitting multiple sclerosis. 204
Increased incidence of multiple sclerosis in the Veneto region, Italy. 188
Cortical lesions and cognitive impairment in multiple sclerosis. 187
Evidence for relative cortical sparing in benign multiple sclerosis: a longitudinal magnetic resonance imaging study 184
Cortical Pathology in RRMS: Taking a Cue from Four Sisters. 183
Intrathecal IgM production at clinical onset correlates with a more severe disease course in multiple sclerosis 177
Crisi epilettiche all’esordio e al follow-up in ADEM ed sclerosi multipla con esordio in età pediatrica: dati a confronto dalla casistica padovana 177
Low degree of cortical pathology is associated with benign course of multiple sclerosis. 172
Switching therapy from natalizumab to fingolimod in relapsing-remitting multiple sclerosis: clinical and magnetic resonance imaging findings. 170
Extensive cortical inflammation is associated with epilepsy in multiple sclerosis 168
Quality of life, depression and fatigue in mildly disabled patients with relapsing-remitting multiple sclerosis receiving subcutaneous interferon beta-1a: 3-year results from the COGIMUS (COGnitive Impairment in MUltiple Sclerosis) study 167
Cyclophosphamide as second-line therapy in multiple sclerosis: benefits and risks 166
Cognitive impairment and its relation with disease measures in mildly disabled patients with relapsing-remitting multiple sclerosis: baseline results from the Cognitive Impairment in Multiple Sclerosis (COGIMUS) study 161
Changes in magnetic resonance imaging disease measures over 3 years in mildly disabled patients with relapsing-remitting multiple sclerosis receiving interferon beta-1a in the COGnitive Impairment in MUltiple Sclerosis (COGIMUS) study 160
Interleukin-1 receptor antagonist, soluble tumor necrosis factor-alpha receptor type I and II, and soluble E-selectin serum levels in multiple sclerosis patients receiving weekly intramuscular injections of interferon-beta1a. 158
Il “mirror IgG pattern” nella diagnostica delle malattie neurologiche. 157
Malattie Infiammatorie del Sistema Nervoso Centrale. 153
Increasing Frequency of Multiple Sclerosis in Padova, Italy. A 30 year epidemiological survey 149
Mitoxantrone versus cyclophosphamide in secondary-progressive multiple sclerosis - A comparative study 149
Multiple sclerosis and autoimmune diseases - Epidemiology and HLA-DR association in North-east Italy 147
Meningiti croniche non infettive. 146
Subcutaneous interferon β-1a may protect against cognitive impairment in patients with relapsing-remitting multiple sclerosis: 5-year follow-up of the COGIMUS study. 146
The safety profile of cyclophosphamide in multiple sclerosis trherapy. 146
The range of multiple sclerosis associated with neurofibromatosis type 1 139
Crebrospinal fluid examination in the differential diagnosis of inflammato ry myelopathies 138
The clinical impact of interferon beta antibodies in relapsing remitting MS 132
Immunotherapies for Multiple Sclerosis. 130
Effect of Immunomodulatory Agents (IMAs) on Cortical Inflammatory Lesions (CLs) in Patients with Relapsing-Remitting Multiple Sclerosis (RRMS): A 2-Year Longitudinal Comparison Study 128
Interferon-beta (INF-beta) antibodies in interferon-beta1a- and interferon-beta1b-treated multiple sclerosis patients. Prevalence, kinetics, cross-reactivity, and factors enhancing interferon-beta immunogenicity in vivo. 126
The changing clinical course of multiple sclerosis: A matter of grey matter. 121
Complicanze neurologiche delle Malattie Dismetaboliche 117
Sclerosi Multipla 116
The MBP-reactive repertoire is shaped by recognition of minor histocompatibility antigens 114
Time-course analysis of CD25 and HLA-DR expression on lymphocytes in interferon-beta 1b-treated multiple sclerosis patients. 111
Autoanticorpi naturali anti-interferone beta (IFNβ) in pazienti con sclerosi multipla trattati con IFNβ1a (Avonex) o IFNβ1b (Betaferon). 109
Anti-interferon beta (IFNbeta) antibodies in IFNbeta1a- or IFNbeta1b-treated relapsing-remitting multiple sclerosis. Prevalence, kinetics, cross-reactivity, and factors enhancing their production in vivo 104
The HLA-DR13 aplotype is associated with benign multiple sclerosis in North-east Italy 80
null 60
Totale 7.407
Salva come PNG Salva come JPEG
Categoria #
all - tutte 20.871
article - articoli 17.454
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 2.432
Totale 40.757
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022427 0 48 51 13 24 50 4 44 29 16 49 99
2022/2023512 105 75 16 72 79 64 5 24 50 1 20 1
2023/2024227 11 46 35 16 7 19 7 26 7 6 22 25
2024/20251.037 4 90 54 46 191 26 38 93 60 34 158 243
2025/20263.401 149 317 482 457 327 102 524 319 381 197 106 40
2026/2027190 110 80 0 0 0 0 0 0 0 0 0 0
Totale 7.407